Yesterday (7 January) at the news conference center on the situation of coronavirus 2019, Ministry of Public Health Nonthaburi Province Dr. Opaskarn Kavinpong Director-General, Department of Disease Control Discussing progress on the COVID-19 vaccine, COVID-19 is a human-to-human transmission, so spaced masks cut down on people-to-face activities. And reduce travel Therefore it is one way to cut the disease cycle And when there is a vaccine, it will help build immunity. But the process of introducing the COVID-19 vaccine There are many steps to come. Both importing vaccines Registration Quality inspection, transportation, storage, injection guidelines for population Monitoring of adverse reactions and vaccine efficacy after injection. This is because the vaccine introduces dead or weak germs into the body. May cause side effects Therefore must be done carefully So that the vaccine is effective and safe In foreign countries, some cases of side effects were found. Some died Which will be checked whether related to the vaccine or not. The Ministry of Health will collect information to notify you from time to time.
.
Dr. Opas continued that As for the implementation of the COVID-19 vaccine in Thailand, the Academic Committee has approved a three phase one, phase 1, providing 2 million doses of the vaccine, divided into February, 2 hundred thousand, March 8 hundred thousand and April 1. Millions of doses were injected into two injections approximately four weeks apart. The goal was to reduce severe illness and death from COVID-19. In the areas with the most infestations first was The highest and strict control areas in 5 provinces are Samut Sakhon, Rayong, Chonburi, Chanthaburi and Trat. The group that will perform the injection first is medical personnel and public health outposts. Both public and private sectors This includes eight thousand volunteers, 20,000 personnel involved in disease control, and people with underlying disease at risk of death such as severe chronic respiratory disease. Cardiovascular disease Chronic kidney disease Stroke, cancer, diabetes and elderly groups 60 years and over, totaling 9 hundred thousand people, if there is a remainder, will be reserved in the event of a severe outbreak in the community to stop the epidemic
.
Phase 2, from May to June 2021, will be injected 26 million doses for vulnerable groups nationwide, and Phase 3 from late 2021 to early 2022 will be injected to the general public to cover as much as possible. To create immunity in the community To cut the cycle of disease outbreaks The Government Pharmaceutical Organization will be the importer and distribute to the hospitals under all levels. Public and private hospitals that participate in the project To provide comprehensive access to the public It will begin enrollment to investigate vaccine risk groups from late January to early February. Organize and rehearse the understanding of vaccination, transportation, storage and surveillance of post-vaccination adverse reactions.
Proofread: Pornnaphat Chamnankha
–
